 OXFORD, United Kingdom, June 14, 2021 GLOBE NEWSWIRE -- Vaccitech plc NASDAQ: VACC, a clinical-stage biopharmaceutical company engaged in the discovery and development of novel immunotherapeutics and vaccines for the treatment and prevention of infectious diseases and cancer, today announced financial results for the quarter ended March 31, 2021, and provided an overview of the Companys recent corporate developments. 